Cancer risk in 892 089 patients with psoriasis in Korea: A nationwide population-based cohort study.
Ji-Hyun LeeHyo Jung KimKyung Do HanHa-Na KimYoung Min ParkJun Young LeeYong-Gyu ParkYoung-Bok LeePublished in: The Journal of dermatology (2018)
The relationship between psoriasis and cancer has not yet been established. The aim of this study was to evaluate the association of psoriasis with certain cancers using national statistics. All patients with psoriasis (n = 892 089; 51.7% male) and age- and sex-matched control subjects (n = 4 460 445) at a 5:1 ratio were enrolled using data from the National Health Insurance Service between 2007 and 2014 in Korea. In psoriatic subjects, overall cancer risk was higher than for subjects without psoriasis after adjusting for income level, diabetes, hypertension, dyslipidemia and place of residence (hazard ratio, 1.065; 95% CI, 1.049-1.081). The risk of cancer increased in the following order: prostate, thyroid, liver, ovarian, lung, leukemia, skin, multiple myeloma, lymphoma and testicular. The severity and sex of psoriatic patients also had different cancer risks. In psoriatic patients, a slightly increased risk for specific malignant neoplasms was shown. Therefore, periodic screening for cancer risk is recommended in patients with psoriasis.
Keyphrases
- end stage renal disease
- papillary thyroid
- health insurance
- rheumatoid arthritis
- ejection fraction
- chronic kidney disease
- prostate cancer
- newly diagnosed
- squamous cell
- multiple myeloma
- cardiovascular disease
- blood pressure
- disease activity
- atopic dermatitis
- mental health
- ankylosing spondylitis
- machine learning
- physical activity
- squamous cell carcinoma
- metabolic syndrome
- patient reported outcomes
- bone marrow
- lymph node metastasis
- childhood cancer
- insulin resistance
- skeletal muscle
- systemic lupus erythematosus
- young adults
- climate change
- weight loss
- artificial intelligence